Expert Review of Vaccines (e-ISSN 1744-8395) is a MEDLINE-indexed, international journal publishing rigorously peer-reviewed research in the development, application, and clinical effectiveness of new vaccines.

The vaccine field has been transformed by recent technological advances, but there remain many challenges in the delivery of cost-effective, safe vaccines. Expert Review of Vaccines facilitates decision making to drive forward this exciting field.

The journal features cutting edge reviews and original articles on vaccines, the immune response, and the powerful impact of immunization against infectious diseases. We also cover vaccine technologies and platforms, adjuvants, therapeutic vaccines and vaccination for the control of non-communicable diseases.

Alongside review articles, the journal welcomes clinically relevant and novel original research. Pharmacoeconomic studies are considered if there is clear clinical relevance. Please note that the journal does not publish case reports or animal studies. Letters to the Editor should discuss articles previously published in the journal.

Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections:

Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results;

Article Highlights – an executive summary of the author’s most critical points.
Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.

 For any pre-submission enquiries, please contact the Commissioning Editor.

Please note, from 2023 the Print ISSN is not in active use as this journal is no longer published in print.

Sergio Abrignani, National Institute of Molecular Genetics, Italy 
Jon Kim Andrus, Sabin Vaccine Institute, Washington DC, USA 
Vasso Apostolopoulos, Victoria University, Melbourne 
Philip M Arlen, Precision Biologics, Washington DC, USA 
P Noel Barrett, Baxter BioScience, Austria 
Igor Belyakov, University of Michigan, MI, USA
Alexander Bukreyev, University of Texas Medical Branch, TX, USA 
Myron Christodoulides, University of Southampton, UK 
John Clemens, UCLA Fielding School of Public Health, USA 
Angus G Dalgleish, St George's Hospital Medical School, UK 
Ronald W Ellis, FutuRx Ltd, Israel
Gregory Glenn, Novavax, MD, USA 
Michael Good, Griffith University, Queensland, Australia 
Stephen Hoffman, Sanaria Inc., MD, USA 
JU Igietseme, CDC Atlanta, GA, USA 
Odile Launay, Paris Descartes University, Cochin Hospital, Paris, France 
Camille Locht, Institut Pasteur de Lille, France 
Alex Loukas, James Cook University, Australia 
Umesh Parashar, Centers for Disease Control and Prevention, Atlanta, Georgia, USA 
Andrew J Pollard, University of Oxford, UK 
Shabir Madhi, National Institute for Communicable Diseases, Johannesburg, South Africa 
Jan Poolman, Johnson & Johnson, Leiden, Netherlands 
Punnee Pitisuttithum, Mahidol University, Bangkok, Thailand 
Rino Rappuoli, Novartis Vaccines, Italy 
Steven G Reed, Infectious Disease Research Institute, WA, USA 
Gus Rimmelzwaan, Erasmus Medical Centre, Rotterdam, The Netherlands 
Larisa Rudenko, Institute of Experimental Medicine, Saint Petersburg, Russia 
Suryaprakash Sambhara, CDC Atlanta, GA, USA 
Alessandro Sette, La Jolla Institute for Allergy and Immunology, CA, USA 
Leonard A. Smith, US Army Medical Research Institute of Infectious Diseases, MD, USA 
De-chu Christopher Tang, International Vaccine Institute, Seoul, Korea 
Ralph A Tripp, The University of Georgia, GA, USA 
Takafumi Tsuboi, Ehime University, Ehime, Japan 
Jeffrey Ulmer, GSK Vaccines, MD, USA 
David B Weiner, University of Pennsylvania School of Medicine, PA, USA 
Annelies Wilder-Smith, Lee Kong Chian School of Medicine, Singapore 
Feng-Cai Zhu, Jiangsu Provincial Center for Disease Control and Prevention, China